Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Kidney International|August 18, 2005
Progression of coronary artery calcification in diabetics with and without chronic kidney diseaseRajnish Mehrotra, Matthew Budoff, John E Hokanson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 14, 2010
Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuriaYi-Wen Chiu, Sharon Adler, Matthew Budoff, et al.
American Journal of Nephrology|October 17, 2002
Peripheral arterial disease is not associated with an increased prevalence of intradialytic cramps in patients on maintenance hemodialysisEric P Brass, Sharon Adler, Kathy E Sietsema, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
Clinical and demographic predictors of exercise capacity in end-stage renal diseaseKathy E Sietsema, William R Hiatt, Anne Esler, et al.
Kidney International|October 22, 2004
Determinants of coronary artery calcification in diabetics with and without nephropathyRajnish Mehrotra, Matthew Budoff, Peter Christenson, et al.
Kidney International|February 9, 2005
Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcificationRajnish Mehrotra, Ralf Westenfeld, Peter Christenson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 18, 2008
Hypovitaminosis D in chronic kidney diseaseRajnish Mehrotra, Dulcie Kermah, Matthew Budoff, et al.
Kidney International Reports|January 18, 2018
Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic SyndromeHoward Trachtman, Debbie S Gipson, Michael Somers, et al.
Glomerular Diseases|August 2, 2021
Kidney Injury Molecule-1 and Periostin Urinary Excretion and Tissue Expression Levels and Association with Glomerular Disease OutcomesQiaoyan Wu, Jonathan P Troost, Tiane Dai, et al.
Kidney International Reports|November 17, 2017
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)Radko Komers, Debbie S Gipson, Peter Nelson, et al.
Pageof 3